Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Neurol Sci ; 41(3): 653-660, 2020 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-31758347

RESUMO

AIM: Evaluation of pediatric palliative home care of families with children suffering from neurodegeneration with brain iron accumulation (NBIA) and their parents. MATERIAL AND METHODS: The children were treated at home by a multidisciplinary team. Densitometry was used to evaluate the condition of the skeletal system. Botulinum toxin was injected into the muscles in doses between 22 and 50 units/kg. The quality of palliative care was assessed on the basis of a specially designed questionnaire for parents. RESULTS: The observations were performed on a group of 9 patients with NBIA. On admission, the median age of patients was 9 years (7-14). The average time of palliative home care was 1569 days (34 days-17 years). The median age at death (6 patients) was 11 years (7-15). The botulinum toxin injections gave the following results: reduction of spasticity and dystonia, reduction of spine and chest deformation, relief of pain and suffering, facilitation of rehabilitation and nursing, prevention of permanent contractures, and reduction of excessive salivation. Bone mineral density and bone strength index were reduced. Two patients experienced pathological fracture of the femur. The body mass index at admission varied between 9.8 and 14.9. In 7 cases, introduction of a ketogenic diet resulted in the increase of body mass and height. The ketogenic diet did not worsen the neurological symptoms. The parents positively evaluated the quality of care. CONCLUSION: Palliative home care is the optimal form of treatment for children with NBIA.


Assuntos
Serviços de Assistência Domiciliar , Distúrbios do Metabolismo do Ferro/terapia , Distrofias Neuroaxonais/terapia , Fármacos Neuromusculares/farmacologia , Cuidados Paliativos/métodos , Adolescente , Doenças Ósseas/tratamento farmacológico , Doenças Ósseas/etiologia , Toxinas Botulínicas/farmacologia , Criança , Distonia/tratamento farmacológico , Distonia/etiologia , Feminino , Humanos , Distúrbios do Metabolismo do Ferro/complicações , Distúrbios do Metabolismo do Ferro/tratamento farmacológico , Distúrbios do Metabolismo do Ferro/enfermagem , Masculino , Espasticidade Muscular/tratamento farmacológico , Espasticidade Muscular/etiologia , Dor Musculoesquelética/tratamento farmacológico , Dor Musculoesquelética/etiologia , Distrofias Neuroaxonais/complicações , Distrofias Neuroaxonais/tratamento farmacológico , Distrofias Neuroaxonais/enfermagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA